Candidate Drug/Lead Compound
Indication
Lead Optimization
IND Enabling
IND Filed
Phase I
Phase II
Phase III

S-011-1793

Malaria

S-016-1348

Cancer (Smac mimetic)

SB-CDRI4-105

Neuropathic pain

GS/IICT 5/6

Anti-angiogenic

S-016-1271

Complicated UTI

Phytolead
Indication
Lead Optimization
IND Enabling
IND Filed
Phase I
Phase II
Phase III

Picroliv

Non-alcoholic fatty liver disease

NMITLI -118 AF1

Stroke

NMITLI -118 PHPL

Bone health

Formulation
API
Indication
Lead Optimization
Subsequent New Drug Application
Phase I
Phase II
Phase III

Centinhale
(Dry powder formulation)

Rifabutin and Isoniazid

MDR TB

Drop your query
Facebook
Instagram
Twitter
linked-In
YouTube
WhatsApp